Navigation Links
New Jersey Health Foundation Awards $50,000 Grant For Research to Facilitate Stem Cell Growth
Date:10/21/2013

NEW BRUNSWICK, N.J., Oct. 21, 2013 /PRNewswire-USNewswire/ -- Dr. Steven Levison has received a $50,000 Innovation Stage Funding Grant from New Jersey Health Foundation to advance research that could make stem cell growth easier and less expensive for researchers, scientists and others interested in using stem cells to advance medical studies.

Dr. Levison, a professor in the Department of Neurology and Neurosciences at Rutgers New Jersey Medical School (NJMS), has worked collaboratively with colleagues at NJMS and at the New Jersey Institute of Technology to develop a multifunctional matrix that allows neural stem cells to be propagated as undifferentiated cells without daily feeding.

"Our cell culture matrices and supplements can be used in regenerative medicine, biotechnology and life science research," explained Dr. Levison. "We can manufacture products that don't contain animal components so that they are suitable for clinical applications."

Dr. Levison explained that he and his research team have formulated and rigorously tested a novel growth matrix that promotes the proliferation and multipotency of neural stem cells. Commercially available matrices today, he said, do not incorporate defined growth factors.  While some matrices do contain growth factors, they are not defined or suitable for therapeutic use.

"We are very interested in helping Dr. Levison advance his research because we believe this product could be commercialized successfully to be of tremendous benefit to the research community," explained Dr. George F. Heinrich, vice chair and CEO of New Jersey Health Foundation.  "His unique product reduces the time-consuming and tedious task of feeding stem cells on a daily basis, which will save researchers time and money."

Dr. Levison and his research team are presently modifying the scaffold to incorporate a variety of growth factors known to be beneficial for propagating other types of stem cells and progenitors. 

Through the Innovation Stage Funding program, New Jersey health Foundation (www.njhf.org) has allocated $500,000 to provide grants from $10,000 to $50,000 each to researchers at the Rutgers School of Biomedical and Health Sciences who have promising ideas to advance an intellectual property toward commercialization through a start-up. 

About New Jersey Health Foundation
New Jersey Health Foundation (www.njhf.org) is a not-for-profit corporation that supports biomedical research and health-related education programs in New Jersey through its matching program, its Grants Program and its affiliate, Foundation Venture Capital Group (www.foundationventure.com) which makes private equity investments in life science start- up companies in New Jersey headed toward commercialization.


'/>"/>
SOURCE New Jersey Health Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunrise Pharmaceutical, Inc. Sued for Violation of New Jersey Consumer Fraud Act
2. Cardiac Science signs contract to provide Powerheart AEDs to the state of New Jersey
3. Big Pharma to Come Together at ChemOutsourcing 2013 in Long Branch, New Jersey, Sept 16-19
4. ChemOutsourcing Announces 100 CMO and CRO Exhibitors for September 2013 Show in Long Branch, New Jersey
5. ChemOutsourcing Announces 30 Pharma Company Presenters for September 2013 Outsourcing Show in New Jersey
6. NJBIZ Honors New Jerseys General Counsels
7. Growth Fuels Expansion As PendoTECH Relocates New Jersey Headquarters
8. South Jersey Healthcare Selects Perioperative Management By Surgical Information Systems
9. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
10. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
11. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology:
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... which is has been collaborating with doctors and hospitals to make transformative changes ... the world’s leading cell therapy minds this week in discussing breakthroughs in cellular ...
(Date:4/28/2016)... ... ... reminds us that May is National Stroke Awareness Month. According to the Centers for ... the United States; someone has one every 40 seconds. Annually, almost 800,000 strokes occur ... A stroke is when blood flow to the brain is blocked or when a ...
(Date:4/28/2016)... Philadelphia, PA (PRWEB) , ... April 28, 2016 ... ... Barbara Browne, M.D. has been named a Top Doc in Physical Medicine and ... in conjunction with Castle Connolly Medical, Ltd. by randomly surveying physicians and medical ...
(Date:4/28/2016)... MO (PRWEB) , ... April 28, 2016 , ... Denise McCormick Baich had written poetry ... 2009 the poetry arrived again much like a tsunami and took on a more spiritual ... to her encouraged her to do more with it than just file it away. Friends ...
(Date:4/28/2016)... ... April 28, 2016 , ... Prescription ... co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy program. ... medications from over 180 American pharmaceutical companies for $35 per month, per ...
Breaking Medicine News(10 mins):